-
1
-
-
0032792906
-
Advances in the treatment of depression
-
Hollander, E. Advances in the treatment of depression. CNS Spectr., 1999, 4(7), 13.
-
(1999)
CNS Spectr
, vol.4
, Issue.7
, pp. 13
-
-
Hollander, E.1
-
2
-
-
0029967073
-
Definition and epidemiology of treatment-resistant depression
-
Fava, M.; Davidson, K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am., 1996, 19(2), 179-200. http://dx.doi.org/10.1016/S0193-953X(05)70283-5
-
(1996)
Psychiatr. Clin. North Am
, vol.19
, Issue.2
, pp. 179-200
-
-
Fava, M.1
Davidson, K.G.2
-
3
-
-
84876738375
-
Targeting glia cells: Novel perspectives for the treatment of neuropsychiatric diseases
-
Di Benedetto, B.; Rupprecht, R.; Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases. Curr. Neuropharmacol., 2013, 11 (2), 171-85. doi:10.2174/1570159X113 11020004.
-
(2013)
Curr. Neuropharmacol
, vol.11
, Issue.2
, pp. 171-185
-
-
Di Benedetto, B.1
Rupprecht, R.2
-
4
-
-
84878396787
-
Glutamate-based antidepressants: Preclinical psychopharmacology
-
Pilc, A.; Wierońska, J.M.; Skolnick, P. Glutamate-based antidepressants: preclinical psychopharmacology. Biol. Psychiatry, 2013, 73(12), 1125-32. doi:10.1016/j.biopsych.2013.01.021.
-
(2013)
Biol. Psychiatry
, vol.73
, Issue.12
, pp. 1125-1132
-
-
Pilc, A.1
Wierońska, J.M.2
Skolnick, P.3
-
5
-
-
84862769027
-
New drug targets in depression: Inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors
-
Maes, M.; Fišar, Z.; Medina, M.; Scapagnini, G.; Nowak, G.; Berk, M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology, 2012, 20(3), 127-50. doi:10.1007/s10787-011-0111-7.
-
(2012)
Inflammopharmacology
, vol.20
, Issue.3
, pp. 127-150
-
-
Maes, M.1
Fišar, Z.2
Medina, M.3
Scapagnini, G.4
Nowak, G.5
Berk, M.6
-
6
-
-
79954989975
-
Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways
-
Maes, M.; Kubera, M. Depression's multiple comorbidities explained by (neuro) inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol. Lett., 2011, 32(1), 7-24.
-
(2011)
Neuro Endocrinol. Lett
, vol.32
, Issue.1
, pp. 7-24
-
-
Maes, M.1
Kubera, M.2
-
7
-
-
84876670027
-
The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications
-
Moylan, S.; Maes, M.; Wray, N.R.; Ber, M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry, 2013, 18(5), 595-606. doi:10.1038/mp.2012.33.
-
(2013)
Mol. Psychiatry
, vol.18
, Issue.5
, pp. 595-606
-
-
Moylan, S.1
Maes, M.2
Wray, N.R.3
Ber, M.4
-
8
-
-
84877091127
-
Potential roles of zinc in the pathophysiology and treatment of major depressive disorder
-
Swardfager, W.; Herrmann, N.; McIntyre, R.S.; Mazereeuw, G.; Goldberger, K.; Cha, D.S.; Schwatz, Y.; Lanctot, K.L. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neurosci. Biobehav. Rev., 2013, 37(5), 911-29. doi:10.1016/j.neubiorev.2013.03.018.
-
(2013)
Neurosci. Biobehav. Rev
, vol.37
, Issue.5
, pp. 911-929
-
-
Swardfager, W.1
Herrmann, N.2
McIntyre, R.S.3
Mazereeuw, G.4
Goldberger, K.5
Cha, D.S.6
Schwatz, Y.7
Lanctot, K.L.8
-
9
-
-
79954575692
-
The role of zinc in neurodegenerative inflammatory pathways in depression
-
Szewczyk, B.; Kubera, M.; Nowak, G. The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol. Biol. Psychiatry, 2011, 35(3), 693-701. doi:10.1016/j.pnpbp.2010.02.010.
-
(2011)
Prog Neuropsychopharmacol. Biol. Psychiatry
, vol.35
, Issue.3
, pp. 693-701
-
-
Szewczyk, B.1
Kubera, M.2
Nowak, G.3
-
10
-
-
84855801183
-
Mechanistic explanations how cellmediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
-
Leonard, B.; Maes, M. Mechanistic explanations how cellmediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev., 2012, 36(2), 764-785. doi: 10.1016/j.neubiorev. 2011.12.005.
-
(2012)
Neurosci. Biobehav. Rev
, vol.36
, Issue.2
, pp. 764-785
-
-
Leonard, B.1
Maes, M.2
-
11
-
-
84892676153
-
Association of depressive symptoms with hippocampal volume in 1936 adults
-
Brown, E.S.; Hughes, C.W.; McColl, R.; Peshock, R.; King, K.S.; Rush, A.J. Association of depressive symptoms with hippocampal volume in 1936 adults. Neuropsychopharmacology, 2014, 39(3), 770-9. doi: 10.1038/npp.2013.271.
-
(2014)
Neuropsychopharmacology
, vol.39
, Issue.3
, pp. 770-779
-
-
Brown, E.S.1
Hughes, C.W.2
McColl, R.3
Peshock, R.4
King, K.S.5
Rush, A.J.6
-
12
-
-
27444434056
-
Beyond monoamines: Glutamatergic function in mood disorders
-
Kugaya, A.; Sanacora, G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr., 2005, 10(10), 808-19.
-
(2005)
CNS Spectr
, vol.10
, Issue.10
, pp. 808-819
-
-
Kugaya, A.1
Sanacora, G.2
-
13
-
-
38949115944
-
Mood disorders: Regulation by metabotropic glutamate receptors
-
Pilc, A.; Chaki, S.; Nowak, G.; Witkin, J.M. Mood disorders: regulation by metabotropic glutamate receptors. Biochem. Pharmacol., 2008, 75(5), 997-1006. doi:10.1016/j.bcp.2007.09.021.
-
(2008)
Biochem Pharmacol
, vol.75
, Issue.5
, pp. 997-1006
-
-
Pilc, A.1
Chaki, S.2
Nowak, G.3
Witkin, J.M.4
-
14
-
-
84855549573
-
Overview of glutamatergic neurotransmission in the nervous system
-
Niciu, M.J.; Kelmendi, B.; Sanacora, G. Overview of glutamatergic neurotransmission in the nervous system. Pharmacol. Biochem. Behav., 2012, 100(4), 656-64. doi:10.1016/j.pbb.2011.08.008.
-
(2012)
Pharmacol. Biochem. Behav
, vol.100
, Issue.4
, pp. 656-664
-
-
Niciu, M.J.1
Kelmendi, B.2
Sanacora, G.3
-
15
-
-
42949123365
-
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
-
Sanacora, G.; Zarate, C. a; Krystal, J.H.; Manji, H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov., 2008, 7(5), 426-37. doi:10.1038/nrd2462.
-
(2008)
Nat. Rev. Drug Discov
, vol.7
, Issue.5
, pp. 426-437
-
-
Sanacora, G.1
Zarate, C.A.2
Krystal, J.H.3
Manji, H.K.4
-
16
-
-
0036386829
-
Modulation of glutamate receptors: Strategies for the development of novel antidepressants
-
Skolnick, P. Modulation of glutamate receptors: strategies for the development of novel antidepressants. Amino Acids, 2002, 23(1-3), 153-9. doi:10.1007/s00726-001-0121-7.
-
(2002)
Amino Acids
, vol.23
, Issue.1-3
, pp. 153-159
-
-
Skolnick, P.1
-
17
-
-
0025157918
-
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
-
Trullas, R.; Skolnick, P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol., 1990, 185(1), 1-10.
-
(1990)
Eur. J. Pharmacol
, vol.185
, Issue.1
, pp. 1-10
-
-
Trullas, R.1
Skolnick, P.2
-
18
-
-
0017651126
-
Behavioral despair in mice: A primary screening test for antidepressants
-
Porsolt, R.D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Thérapie, 1977, 229(2), 327-36.
-
(1977)
Arch. Int. Pharmacodyn. Thérapie
, vol.229
, Issue.2
, pp. 327-336
-
-
Porsolt, R.D.1
Bertin, A.2
Jalfre, M.3
-
19
-
-
0021990491
-
The tail suspension test: A new method for screening antidepressants in mice
-
Steru, L.; Chermat, R.; Thierry, B.; Simon, P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl), 1985, 85(3), 367-70.
-
(1985)
Psychopharmacology (Berl)
, vol.85
, Issue.3
, pp. 367-370
-
-
Steru, L.1
Chermat, R.2
Thierry, B.3
Simon, P.4
-
20
-
-
84902468722
-
Essential elements in depression and anxiety. Part I
-
Młyniec, K.; Davies, C.L.; de Aguero Sanchez, I.G.; Pytka, K.; Budziszewska, B.; Nowak, G. Essential elements in depression and anxiety. Part I. Pharmacol. Reports, 2014, 66(4), 534-44. doi:http://dx.doi.org/10.1016/j.pharep.2014.03.001.
-
(2014)
Pharmacol. Reports
, vol.66
, Issue.4
, pp. 534-544
-
-
Młyniec, K.1
Davies, C.L.2
de Aguero Sanchez, I.G.3
Pytka, K.4
Budziszewska, B.5
Nowak, G.6
-
21
-
-
0027817396
-
New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors
-
Papp, M.; Moryl, E. New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors. Pol. J. Pharmacol., 1993, 45(5-6), 549-53.
-
(1993)
Pol. J. Pharmacol
, vol.45
, Issue.5-6
, pp. 549-553
-
-
Papp, M.1
Moryl, E.2
-
22
-
-
0027967222
-
Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression
-
Papp, M.; Moryl, E. Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol., 1994, 263(1-2), 1-7.
-
(1994)
Eur. J. Pharmacol
, vol.263
, Issue.1-2
, pp. 1-7
-
-
Papp, M.1
Moryl, E.2
-
23
-
-
79953166373
-
Glutamate N-methyl-Daspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure
-
Li, N.; Liu, R.-J.; Dwyer, J.M.; Banasr, M., Lee, B., Son, H., Li, X.Y., Aghajanian, G., Duman, R.S. Glutamate N-methyl-Daspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry, 2011, 69(8), 754-61. doi:10.1016/j.biopsych.2010.12.015.
-
(2011)
Biol. Psychiatry
, vol.69
, Issue.8
, pp. 754-761
-
-
Li, N.1
Liu, R.-J.2
Dwyer, J.M.3
Banasr, M.4
Lee, B.5
Son, H.6
Li, X.Y.7
Aghajanian, G.8
Duman, R.S.9
-
24
-
-
33645120386
-
A role for AMPA receptors in mood disorders
-
Alt, A.; Nisenbaum, E.S.; Bleakman, D.; Witkin, J.M. A role for AMPA receptors in mood disorders. Biochem. Pharmacol., 2006, 71(9), 1273-88. doi:10.1016/j.bcp.2005.12.022.
-
(2006)
Biochem. Pharmacol
, vol.71
, Issue.9
, pp. 1273-1288
-
-
Alt, A.1
Nisenbaum, E.S.2
Bleakman, D.3
Witkin, J.M.4
-
25
-
-
0036751341
-
LY404187: A novel positive allosteric modulator of AMPA receptors
-
Quirk, J.C.; Nisenbaum, E.S. LY404187: A novel positive allosteric modulator of AMPA receptors. CNS Drug Rev., 2002, 8(3), 255-82.
-
(2002)
CNS Drug Rev
, vol.8
, Issue.3
, pp. 255-282
-
-
Quirk, J.C.1
Nisenbaum, E.S.2
-
26
-
-
77957231941
-
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
-
Farley, S.; Apazoglou, K.; Witkin, J.M.; Giroz, B.; Tzavara, E.T. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int. J. Neuropsychopharmacol., 2010, 13(9), 1207-18. doi:10.1017/S1461145709991076.
-
(2010)
Int. J. Neuropsychopharmacol
, vol.13
, Issue.9
, pp. 1207-1218
-
-
Farley, S.1
Apazoglou, K.2
Witkin, J.M.3
Giroz, B.4
Tzavara, E.T.5
-
27
-
-
0034986979
-
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
-
Li, X.; Tizzano, J.P.; Griffey, K.; Clay, M.; Lindstrom, T.; Skolnick, P. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology, 2001, 40(8), 1028-33.
-
(2001)
Neuropharmacology
, vol.40
, Issue.8
, pp. 1028-1033
-
-
Li, X.1
Tizzano, J.P.2
Griffey, K.3
Clay, M.4
Lindstrom, T.5
Skolnick, P.6
-
28
-
-
84894131906
-
Is the mGlu5 receptor a possible target for new antidepressant drugs?
-
Pałucha-Poniewiera, A.; Wierońska, J.M.; Brański, P.; Burnat, G.; Chuścicka, B.; Pilc, A. Is the mGlu5 receptor a possible target for new antidepressant drugs? Pharmacol. Rep., 2013, 65(6), 1506-11.
-
(2013)
Pharmacol. Rep
, vol.65
, Issue.6
, pp. 1506-1511
-
-
Pałucha-Poniewiera, A.1
Wierońska, J.M.2
Brański, P.3
Burnat, G.4
Chuścicka, B.5
Pilc, A.6
-
29
-
-
84872166978
-
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
-
Chaki, S.; Ago, Y.; Palucha-Paniewiera, A.; Matrisciano, F.; Pilc, A. mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants. Neuropharmacology, 2013, 66, 40-52. doi:10. 1016/j.neuropharm.2012.05.022.
-
(2013)
Neuropharmacology
, vol.66
, pp. 40-52
-
-
Chaki, S.1
Ago, Y.2
Palucha-Paniewiera, A.3
Matrisciano, F.4
Pilc, A.5
-
30
-
-
33751190762
-
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests
-
Belozertseva, I. V; Kos, T.; Popik, P.; Danysz, W.; Bespalov, A.Y. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur. Neuropsychopharmacol., 2007, 17(3), 172-9. doi:10.1016/j.euroneuro. 2006.03.002.
-
(2007)
Eur. Neuropsychopharmacol
, vol.17
, Issue.3
, pp. 172-179
-
-
Belozertseva, I.V.1
Kos, T.2
Popik, P.3
Danysz, W.4
Bespalov, A.Y.5
-
31
-
-
84902468722
-
Essential elements in depression and anxiety. Part I
-
Młyniec, K.; Davies, C.L.; de Aguero Sanchez, I.G.; Pytka, K.; Budziszewska, B.; Nowak, G. Essential elements in depression and anxiety. Part I. Pharmacol. Rep., 2014, 66(4), 534-44. doi:10.1016/ j.pharep.2014.03.001.
-
(2014)
Pharmacol. Rep
, vol.66
, Issue.4
, pp. 534-544
-
-
Młyniec, K.1
Davies, C.L.2
de Aguero Sanchez, I.G.3
Pytka, K.4
Budziszewska, B.5
Nowak, G.6
-
32
-
-
84884472397
-
Magnesium in depression
-
Serefko, A.; Szopa, A.; Wlaź, P.; Nowak, G.; Radziwoń-Zaleska, M.; Skalski, M.; Poleszak, E. Magnesium in depression. Pharmacol. Rep., 2013, 65(3), 547-54.
-
(2013)
Pharmacol. Rep
, vol.65
, Issue.3
, pp. 547-554
-
-
Serefko, A.1
Szopa, A.2
Wlaź, P.3
Nowak, G.4
Radziwoń-Zaleska, M.5
Skalski, M.6
Poleszak, E.7
-
33
-
-
9644288037
-
Magnesium-deficient diet alters depression-and anxiety-related behavior in mice--influence of desipramine and Hypericum perforatum extract
-
Singewald, N.; Sinner, C.; Hetzenauer, A.; Sartori, S.B.; Murck, H. Magnesium-deficient diet alters depression-and anxiety-related behavior in mice--influence of desipramine and Hypericum perforatum extract. Neuropharmacology, 2004, 47(8), 1189-97. doi:10.1016/j.neuropharm.2004.08.010.
-
(2004)
Neuropharmacology
, vol.47
, Issue.8
, pp. 1189-1197
-
-
Singewald, N.1
Sinner, C.2
Hetzenauer, A.3
Sartori, S.B.4
Murck, H.5
-
34
-
-
80054104942
-
Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment
-
Sartori, S.B.; Whittle, N.; Hetzenauer, A.; Singewald, N. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology, 2012, 62(1), 304-12. doi:10.1016/j.neuropharm.2011.07.027.
-
(2012)
Neuropharmacology
, vol.62
, Issue.1
, pp. 304-312
-
-
Sartori, S.B.1
Whittle, N.2
Hetzenauer, A.3
Singewald, N.4
-
35
-
-
84933179964
-
Dietary magnesium restriction reduces amygdalahypothalamic GluN1 receptor complex levels in mice
-
Ghafari, M.; Whittle, N.; Miklosi, A.G.; Kotlowsky, C.; Schmuckermair, C.; Berger, J.; Bennett, K.L.; Singewald, N.; Lubec, G. Dietary magnesium restriction reduces amygdalahypothalamic GluN1 receptor complex levels in mice. Brain Struct. Funct., 2014, doi:10.1007/s00429-014-0779-8.
-
(2014)
Brain Struct. Funct
-
-
Ghafari, M.1
Whittle, N.2
Miklosi, A.G.3
Kotlowsky, C.4
Schmuckermair, C.5
Berger, J.6
Bennett, K.L.7
Singewald, N.8
Lubec, G.9
-
36
-
-
84906068528
-
NMDA antagonists under investigation for the treatment of major depressive disorder
-
Pochwat, B.; Pałucha-Poniewiera, A.; Szewczyk, B.; Pilc, A.; Nowak, G. NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin. Investig. Drugs, 2014, , 1-12. doi:10.1517/13543784.2014.918951.
-
(2014)
Expert Opin. Investig. Drugs
, pp. 1-12
-
-
Pochwat, B.1
Pałucha-Poniewiera, A.2
Szewczyk, B.3
Pilc, A.4
Nowak, G.5
-
37
-
-
60049088686
-
D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice
-
Poleszak, E.; Szewczyk, B.; Wlaź, A.; Fidecka, S.; Wlaź, P.; Pilc, A.; Nowak, G. D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacol. Rep., 2008, 60(6), 996-1000.
-
(2008)
Pharmacol. Rep
, vol.60
, Issue.6
, pp. 996-1000
-
-
Poleszak, E.1
Szewczyk, B.2
Wlaź, A.3
Fidecka, S.4
Wlaź, P.5
Pilc, A.6
Nowak, G.7
-
38
-
-
0032983086
-
Antidepressants for the new millennium
-
Skolnick, P. Antidepressants for the new millennium. Eur. J. Pharmacol., 1999, 375(1-3), 31-40.
-
(1999)
Eur. J. Pharmacol
, vol.375
, Issue.1-3
, pp. 31-40
-
-
Skolnick, P.1
-
39
-
-
35848939420
-
Increased levels of glutamate in brains from patients with mood disorders
-
Hashimoto, K.; Sawa, A.; Iyo, M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry, 2007, 62(11), 1310-6. doi:10.1016/j.biopsych.2007.03.017.
-
(2007)
Biol. Psychiatry
, vol.62
, Issue.11
, pp. 1310-1316
-
-
Hashimoto, K.1
Sawa, A.2
Iyo, M.3
-
40
-
-
0028900455
-
Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims
-
Nowak, G.; Ordway, G.A.; Paul, I.A. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res., 1995, 675(1-2), 157-64.
-
(1995)
Brain Res
, vol.675
, Issue.1-2
, pp. 157-164
-
-
Nowak, G.1
Ordway, G.A.2
Paul, I.A.3
-
41
-
-
33746896935
-
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
-
Zarate, C.A.; Singh, J.B.; Carlson, P.J.; Carlson, P.J.; Brutsche, N.E.; Ameli, R.; Luckenbaugh, D.A.; Charney, D.S.; Manji, H.K. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry, 2006, 63(8), 856-64. doi:10.1001/archpsyc.63.8.856.
-
(2006)
Arch. Gen. Psychiatry
, vol.63
, Issue.8
, pp. 856-864
-
-
Zarate, C.A.1
Singh, J.B.2
Carlson, P.J.3
Carlson, P.J.4
Brutsche, N.E.5
Ameli, R.6
Luckenbaugh, D.A.7
Charney, D.S.8
Manji, H.K.9
-
42
-
-
84896720531
-
Ketamine as antidepressant? Current state and future perspectives
-
Hasselmann, H.W.W. Ketamine as antidepressant? Current state and future perspectives. Curr. Neuropharmacol., 2014, 12(1), 57-70. doi:10.2174/1570159X113119990043.
-
(2014)
Curr. Neuropharmacol
, vol.12
, Issue.1
, pp. 57-70
-
-
Hasselmann, H.W.W.1
-
43
-
-
84861099072
-
Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial
-
Zarate, C.A.; Brutsche, N.E.; Ibrahim, L.; Franco-Chaves, J.; Diazgranados, N.; Cravchik, A.; Selter, J.; Marquardt, C.A.; Liberty, V.; Luckenbaugh, D.A. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol. Psychiatry, 2012, 71(11), 939-46. doi:10.1016/j.biopsych.2011.12.010.
-
(2012)
Biol. Psychiatry
, vol.71
, Issue.11
, pp. 939-946
-
-
Zarate, C.A.1
Brutsche, N.E.2
Ibrahim, L.3
Franco-Chaves, J.4
Diazgranados, N.5
Cravchik, A.6
Selter, J.7
Marquardt, C.A.8
Liberty, V.9
Luckenbaugh, D.A.10
-
44
-
-
0033969685
-
Antidepressant effects of ketamine in depressed patients
-
Berman, R.M.; Cappiello, A.; Anand, A.; Oren, D.A.; Heninger, G.R.; Charney, D.S.; Krystal, J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry, 2000, 47(4), 351-4.
-
(2000)
Biol. Psychiatry
, vol.47
, Issue.4
, pp. 351-354
-
-
Berman, R.M.1
Cappiello, A.2
Anand, A.3
Oren, D.A.4
Heninger, G.R.5
Charney, D.S.6
Krystal, J.H.7
-
45
-
-
1442264398
-
An open-label trial of riluzole in patients with treatment-resistant major depression
-
Zarate, C.A.; Payne, J.L.; Quiroz, J.; Sporn, J.; Denicoff, K.K.; Luckenbaugh, D.; Charney, D.S.; Manji, H.K. An open-label trial of riluzole in patients with treatment-resistant major depression. Am. J. Psychiatry, 2004, 161(1), 171-4.
-
(2004)
Am. J. Psychiatry
, vol.161
, Issue.1
, pp. 171-174
-
-
Zarate, C.A.1
Payne, J.L.2
Quiroz, J.3
Sporn, J.4
Denicoff, K.K.5
Luckenbaugh, D.6
Charney, D.S.7
Manji, H.K.8
-
46
-
-
59049098262
-
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder
-
Preskorn, S.H.; Baker, B.; Kolluri, S.; Menniti, F.S.; Krams, M.; Landen, J.W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder. J. Clin. Psychopharmacol., 2008, 28(6), 631-7. doi:10.1097/JCP.0b013e31818a6cea.
-
(2008)
J. Clin. Psychopharmacol
, vol.28
, Issue.6
, pp. 631-637
-
-
Preskorn, S.H.1
Baker, B.2
Kolluri, S.3
Menniti, F.S.4
Krams, M.5
Landen, J.W.6
-
47
-
-
0024779411
-
Neurobiology of zinc and zinc-containing neurons
-
Frederickson, C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol., 1989, 31, 145-238.
-
(1989)
Int. Rev. Neurobiol
, vol.31
, pp. 145-238
-
-
Frederickson, C.J.1
-
48
-
-
20144377557
-
The neurobiology of zinc in health and disease
-
Frederickson, C.J.; Koh, J.-Y.; Bush, A.I. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci., 2005, 6(6), 449-62. doi:10.1038/nrn1671.
-
(2005)
Nat. Rev. Neurosci
, vol.6
, Issue.6
, pp. 449-462
-
-
Frederickson, C.J.1
Koh, J.-Y.2
Bush, A.I.3
-
49
-
-
0004608219
-
Importance of zinc in the central nervous system: The zinc-containing neuron
-
Frederickson, C.J.; Suh, S.W.; Silva, D.; Frederickson, C.J.; Thompson, R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J. Nutr., 2000, 130(5S Suppl), 1471S-83S.
-
(2000)
J. Nutr
, vol.130
, Issue.5
, pp. 1471S-1483S
-
-
Frederickson, C.J.1
Suh, S.W.2
Silva, D.3
Frederickson, C.J.4
Thompson, R.B.5
-
50
-
-
58149467940
-
Zinc at glutamatergic synapses
-
Paoletti, P.; Vergnano, a M.; Barbour, B.; Casado, M. Zinc at glutamatergic synapses. Neuroscience, 2009, 158(1), 126-36. doi:10.1016/j.neuroscience.2008.01.061.
-
(2009)
Neuroscience
, vol.158
, Issue.1
, pp. 126-136
-
-
Paoletti, P.1
Vergnano, A.M.2
Barbour, B.3
Casado, M.4
-
51
-
-
0242660337
-
Zn2+ transporters and Zn2+ homeostasis in neurons
-
Colvin, R. a.; Fontaine, C.P.; Laskowski, M.; Thomas, D. Zn2+ transporters and Zn2+ homeostasis in neurons. Eur. J. Pharmacol., 2003, 479(1-3), 171-85. doi:10.1016/j.ejphar.2003.08.067.
-
(2003)
Eur. J. Pharmacol
, vol.479
, Issue.1-3
, pp. 171-185
-
-
Colvin, R.A.1
Fontaine, C.P.2
Laskowski, M.3
Thomas, D.4
-
52
-
-
60549107866
-
Zinc and cortical plasticity
-
Nakashima, A.S.; Dyck, R.H. Zinc and cortical plasticity. Brain Res. Rev., 2009, 59(2), 347-73. doi:10.1016/j.brainresrev.2008.10.003.
-
(2009)
Brain Res. Rev
, vol.59
, Issue.2
, pp. 347-373
-
-
Nakashima, A.S.1
Dyck, R.H.2
-
53
-
-
58149269461
-
Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice
-
Whittle, N.; Lubec, G.; Singewald, N.; Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids, 2009, 36 (1), 147-58. doi:10.1007/s00726-008-0195-6.
-
(2009)
Amino Acids
, vol.36
, Issue.1
, pp. 147-158
-
-
Whittle, N.1
Lubec, G.2
Singewald, N.3
-
54
-
-
51149092387
-
Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drugseeking behaviors
-
Milton, A.L.; Lee, J.L.; Butler, V.J.; Gardner, R.; Everitt, B.J. Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drugseeking behaviors. J. Neurosci., 2008, 28(33), 8230-7. doi: 10.1523/JNEUROSCI.1723-08.2008.
-
(2008)
J. Neurosci
, vol.28
, Issue.33
, pp. 8230-8237
-
-
Milton, A.L.1
Lee, J.L.2
Butler, V.J.3
Gardner, R.4
Everitt, B.J.5
-
55
-
-
84868513933
-
The role of the GPR39 receptor in zinc deficientanimal model of depression
-
Młyniec, K.; Budziszewska, B.; Reczyński, W.; Sowa-Kućma, M.; Nowak, G. The role of the GPR39 receptor in zinc deficientanimal model of depression. Behav. Brain Res., 2013, 238, 30-5. doi:10.1016/j.bbr.2012.10.020.
-
(2013)
Behav. Brain Res
, vol.238
, pp. 30-35
-
-
Młyniec, K.1
Budziszewska, B.2
Reczyński, W.3
Sowa-Kućma, M.4
Nowak, G.5
-
56
-
-
84862207373
-
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants
-
Młyniec, K.; Nowak, G.; Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants. Pharmacol. Rep., 2012, 64 (2), 249-55.
-
(2012)
Pharmacol. Rep
, vol.64
, Issue.2
, pp. 249-255
-
-
Młyniec, K.1
Nowak, G.2
-
57
-
-
84884490256
-
Zinc deficiency alters responsiveness to antidepressant drugs in mice
-
Młyniec, K.; Budziszewska, B.; Reczyński, W.; Doboszewska, U.; Pilc, A.; Nowak, G. Zinc deficiency alters responsiveness to antidepressant drugs in mice. Pharmacol. Rep., 2013, 65(3), 579-92.
-
(2013)
Pharmacol. Rep
, vol.65
, Issue.3
, pp. 579-592
-
-
Młyniec, K.1
Budziszewska, B.2
Reczyński, W.3
Doboszewska, U.4
Pilc, A.5
Nowak, G.6
-
58
-
-
84866105041
-
Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test
-
Młyniec, K.; Davies, C.L.; Budziszewska, B.; Opoka, W.; Reczyński, W.; Sowa-Kućma, M.; Doboszewska, U.; Pilc, A.; Nowak, G. Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol. Rep., 2012, 64(3), 567-75.
-
(2012)
Pharmacol. Rep
, vol.64
, Issue.3
, pp. 567-575
-
-
Młyniec, K.1
Davies, C.L.2
Budziszewska, B.3
Opoka, W.4
Reczyński, W.5
Sowa-Kućma, M.6
Doboszewska, U.7
Pilc, A.8
Nowak, G.9
-
59
-
-
52949083151
-
Zinc deficiency induces depression-like symptoms in adult rats
-
Tassabehji, N.M.; Corniola, R.S.; Alshingiti, A.; Levenson, C.W. Zinc deficiency induces depression-like symptoms in adult rats. Physiol. Behav., 2008, 95(3), 365-9. doi:10.1016/j.physbeh.2008. 06.017.
-
(2008)
Physiol. Behav
, vol.95
, Issue.3
, pp. 365-369
-
-
Tassabehji, N.M.1
Corniola, R.S.2
Alshingiti, A.3
Levenson, C.W.4
-
60
-
-
77049125930
-
Susceptibility to stress in young rats after 2-week zinc deprivation
-
Watanabe, M.; Tamano, H.; Kikuchi, T.; Takeda, A. Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochem. Int., 2010, 56(3), 410-6. doi:10.1016/j.neuint.2009.11.014.
-
(2010)
Neurochem. Int
, vol.56
, Issue.3
, pp. 410-416
-
-
Watanabe, M.1
Tamano, H.2
Kikuchi, T.3
Takeda, A.4
-
61
-
-
56349150775
-
Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan
-
Takeda, A.; Tamano, H.; Itoh, H.; Oku, N. Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan. Neurochem. Int., 2008, 53(6-8), 230-5. doi:10.1016/j.neuint.2008. 07.009.
-
(2008)
Neurochem. Int
, vol.53
, Issue.6-8
, pp. 230-235
-
-
Takeda, A.1
Tamano, H.2
Itoh, H.3
Oku, N.4
-
62
-
-
84893172015
-
Zinc deficiency is common in several psychiatric disorders
-
Gronli, O.; Kvamme, J.M.; Friborg, O.; Wynn, R. Zinc deficiency is common in several psychiatric disorders. PLoS One, 2013, 8(12), e82793. doi:10.1371/journal.pone.0082793.
-
(2013)
PLoS One
, vol.8
, Issue.12
-
-
Gronli, O.1
Kvamme, J.M.2
Friborg, O.3
Wynn, R.4
-
63
-
-
84927931956
-
Biological consequences of zinc deficiency in the pathomechanisms of selected diseases
-
Jurowski, K.; Szewczyk, B.; Nowak, G.; Piekoszewski, W. Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. J. Biol. Inorg. Chem., 2014, 19(7), 1069-79. doi:10.1007/s00775-014-1139-0.
-
(2014)
J. Biol. Inorg. Chem
, vol.19
, Issue.7
, pp. 1069-1079
-
-
Jurowski, K.1
Szewczyk, B.2
Nowak, G.3
Piekoszewski, W.4
-
64
-
-
0033665173
-
Zinc exhibits an antidepressant-like effect in the forced swimming test in mice
-
Kroczka, B.; Zieba, A.; Dudek, D.; Pilc, A.; Nowak, G. Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol. J. Pharmacol., 2000, 52(5), 403-6.
-
(2000)
Pol. J. Pharmacol
, vol.52
, Issue.5
, pp. 403-406
-
-
Kroczka, B.1
Zieba, A.2
Dudek, D.3
Pilc, A.4
Nowak, G.5
-
65
-
-
0035872392
-
Antidepressant-like properties of zinc in rodent forced swim test
-
Kroczka, B.; Branski, P.; Palucha, A; Pilc, A.; Nowak, G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res. Bull., 2001, 55(2), 297-300.
-
(2001)
Brain Res. Bull
, vol.55
, Issue.2
, pp. 297-300
-
-
Kroczka, B.1
Branski, P.2
Palucha, A.3
Pilc, A.4
Nowak, G.5
-
66
-
-
0037707701
-
Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats
-
Nowak, G.; Szewczyk, B.; Wieronska, J.M.; Brański, P.; Palucha, A.; Pilc, A.; Sadlik, K.; Piekoszewski, W. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull., 2003, 61(2), 159-64.
-
(2003)
Brain Res. Bull
, vol.61
, Issue.2
, pp. 159-164
-
-
Nowak, G.1
Szewczyk, B.2
Wieronska, J.M.3
Brański, P.4
Palucha, A.5
Pilc, A.6
Sadlik, K.7
Piekoszewski, W.8
-
67
-
-
0042388369
-
Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice
-
Rosa, A.O.; Lin, J.; Calixto, J.B.; Santos, A.R.; Rodrigues, A.L. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res., 2003, 144(1-2), 87-93. doi:10.1016/S0166-4328(03) 00069-X.
-
(2003)
Behav. Brain Res
, vol.144
, Issue.1-2
, pp. 87-93
-
-
Rosa, A.O.1
Lin, J.2
Calixto, J.B.3
Santos, A.R.4
Rodrigues, A.L.5
-
68
-
-
0036965660
-
Interaction of zinc with antidepressants in the forced swimming test in mice
-
Szewczyk, B.; Brański, P.; Wierońska, J.M.; Pałucha, A.; Pilc, A.; Nowak, G. Interaction of zinc with antidepressants in the forced swimming test in mice. Pol. J. Pharmacol., 2002, 54(6), 681-5.
-
(2002)
Pol. J. Pharmacol
, vol.54
, Issue.6
, pp. 681-685
-
-
Szewczyk, B.1
Brański, P.2
Wierońska, J.M.3
Pałucha, A.4
Pilc, A.5
Nowak, G.6
-
69
-
-
56449095880
-
Interaction of zinc with antidepressants in the tail suspension test
-
Cunha, M.P.; Machado, D.G.; Bettio, L.E.B.; Capra, J.C.; Rodrigues, A.L. Interaction of zinc with antidepressants in the tail suspension test. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(8), 1913-20. doi:10.1016/j.pnpbp.2008.09.006.
-
(2008)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.32
, Issue.8
, pp. 1913-1920
-
-
Cunha, M.P.1
Machado, D.G.2
Bettio, L.E.B.3
Capra, J.C.4
Rodrigues, A.L.5
-
70
-
-
60049095030
-
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test
-
Szewczyk, B.; Poleszak, E.; Wlaź, P.; Wrobel, A.; Blicharska, E.; Cichy, A.; Dybała, M.; Siwek, A.; Pomierny-Chamioło, L.; Piotrowska, A.; Brański, P.; Pilc, A.; Nowak, G. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2009, 33(2), 323-9. doi:10.1016/j.pnpbp.2008.12.011.
-
(2009)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.33
, Issue.2
, pp. 323-329
-
-
Szewczyk, B.1
Poleszak, E.2
Wlaź, P.3
Wrobel, A.4
Blicharska, E.5
Cichy, A.6
Dybała, M.7
Siwek, A.8
Pomierny-Chamioło, L.9
Piotrowska, A.10
Brański, P.11
Pilc, A.12
Nowak, G.13
-
71
-
-
57049188838
-
Antidepressant-like activity of zinc: Further behavioral and molecular evidence
-
Sowa-Kućma, M.; Legutko, B.; Szewczyk, B.; Novak, K.; Znojek, P.; Poleszak, E.; Papp, M.; Pilc, A.; Nowak, G. Antidepressant-like activity of zinc: further behavioral and molecular evidence. J. Neural Transm., 2008, 115(12), 1621-8. doi:10.1007/s00702-008-0115-7.
-
(2008)
J. Neural Transm
, vol.115
, Issue.12
, pp. 1621-1628
-
-
Sowa-Kućma, M.1
Legutko, B.2
Szewczyk, B.3
Novak, K.4
Znojek, P.5
Poleszak, E.6
Papp, M.7
Pilc, A.8
Nowak, G.9
-
72
-
-
34047132847
-
Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats
-
Cieślik, K.; Klenk-Majewska, B.; Danilczuk, Z.; Wrobel, A.; Łupina, T.; Ossowska, G.Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol. Rep., 2007, 59 (1), 46-52.
-
(2007)
Pharmacol. Rep
, vol.59
, Issue.1
, pp. 46-52
-
-
Cieślik, K.1
Klenk-Majewska, B.2
Danilczuk, Z.3
Wrobel, A.4
Łupina, T.5
Ossowska, G.6
-
73
-
-
0037707701
-
Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats
-
Nowak, G.; Szewczyk, B.; Wieronska, J.M.; Brański, P.; Pałucha, A.; Pilca, A.; Sadlik, K.; Piekoszewski, W. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res. Bull., 2003, 61(2), 159-64. doi:10.1016/S0361-9230(03)00104-7.
-
(2003)
Brain Res. Bull
, vol.61
, Issue.2
, pp. 159-164
-
-
Nowak, G.1
Szewczyk, B.2
Wieronska, J.M.3
Brański, P.4
Pałucha, A.5
Pilca, A.6
Sadlik, K.7
Piekoszewski, W.8
-
74
-
-
84872417175
-
Acuteadministration of zn, mg, and thiamine improves postpartumdepression conditions in mice
-
Nikseresht, S.; Etebary, S.; Karimian, M.; Nabavizadeh, F.; Zarrindast, M.R.; Sadeghipour, H.R.; Acuteadministration of zn, mg, and thiamine improves postpartumdepression conditions in mice. Arch. Iran Med., 2012, 15 (5), 306-11.doi:012155/AIM.0012.
-
(2012)
Arch. Iran Med
, vol.15
, Issue.5
, pp. 306-311
-
-
Nikseresht, S.1
Etebary, S.2
Karimian, M.3
Nabavizadeh, F.4
Zarrindast, M.R.5
Sadeghipour, H.R.6
-
75
-
-
84887017134
-
Postpartum depression and role of serum trace elements
-
Etebary, S.; Nikseresht, S.; Sadeghipour, H.R.; Zarrindast, M.R. Postpartum depression and role of serum trace elements. Iran J. Psychiatry, 2010, 5(2), 40-6.
-
(2010)
Iran J. Psychiatry
, vol.5
, Issue.2
, pp. 40-46
-
-
Etebary, S.1
Nikseresht, S.2
Sadeghipour, H.R.3
Zarrindast, M.R.4
-
76
-
-
0042388369
-
Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice
-
Rosa, A.O.; Lin, J.; Calixto, J.B.; Santos, A.R.; Rodrigues, A.L. Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav. Brain Res., 2003, 144(1-2), 87-93. doi:10.1016/S0166-4328(03) 00069-X.
-
(2003)
Behav. Brain Res
, vol.144
, Issue.1-2
, pp. 87-93
-
-
Rosa, A.O.1
Lin, J.2
Calixto, J.B.3
Santos, A.R.4
Rodrigues, A.L.5
-
77
-
-
0035074734
-
Identifying populations at risk of zinc deficiency: The use of supplementation trials
-
Hotz, C.; Brown, K.H. Identifying populations at risk of zinc deficiency: the use of supplementation trials. Nutr. Rev., 2001, 59(3 Pt 1), 80-4.
-
(2001)
Nutr. Rev
, vol.59
, Issue.3
, pp. 80-84
-
-
Hotz, C.1
Brown, K.H.2
-
78
-
-
0025633412
-
Zinc in depressive disorder
-
McLoughlin, I.J.; Hodge, J.S. Zinc in depressive disorder. Acta Psychiatr. Scand, 1990, 82(6), 451-3.
-
(1990)
Acta Psychiatr. Scand
, vol.82
, Issue.6
, pp. 451-453
-
-
McLoughlin, I.J.1
Hodge, J.S.2
-
79
-
-
0033379156
-
Lower serum zinc in major depression in relation to changes in serum acute phase proteins
-
Maes, M.; De Vos, N.; Demedts, P.;Wauters, A.; Neels, H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J. Affect. Disord., 1999, 56(2-3), 189-94.
-
(1999)
J. Affect. Disord
, vol.56
, Issue.2-3
, pp. 189-194
-
-
Maes, M.1
De Vos, N.2
Demedts, P.3
Wauters, A.4
Neels, H.5
-
80
-
-
69949143152
-
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study
-
Siwek, M.; Dudek, D.; Paul, I.A.; Sowa-Kućma, M.; Zięba, A.; Popik, P.; Pilc, A.; Nowak. G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J. Affect Disord., 2009, 118(1-3), 187-95. doi:10.1016/j.jad.2009.02.014.
-
(2009)
J. Affect Disord
, vol.118
, Issue.1-3
, pp. 187-195
-
-
Siwek, M.1
Dudek, D.2
Paul, I.A.3
Sowa-Kućma, M.4
Zięba, A.5
Popik, P.6
Pilc, A.7
Nowak, G.8
-
81
-
-
84888045691
-
Zinc in depression: A meta-analysis
-
Swardfager, W.; Herrmann, N.; Mazereeuw, G.; et al. Zinc in depression: a meta-analysis. Biol. Psychiatry, 2013, 74(12), 872-8. doi:10.1016/j.biopsych.2013.05.008.
-
(2013)
Biol. Psychiatry
, vol.74
, Issue.12
, pp. 872-878
-
-
Swardfager, W.1
Herrmann, N.2
Mazereeuw, G.3
-
82
-
-
33748672480
-
Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels
-
Wojcik, J.; Dudek, D.; Schlegel-Zawadzka, M.; Grabowska, M.; Marcinek, A.; Florek, E.; Piekoszewski, W.; Nowak, R.J.; Opoka, W.; Nowak, G. Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol. Rep., 2006, 58(4), 571-6.
-
(2006)
Pharmacol. Rep
, vol.58
, Issue.4
, pp. 571-576
-
-
Wojcik, J.1
Dudek, D.2
Schlegel-Zawadzka, M.3
Grabowska, M.4
Marcinek, A.5
Florek, E.6
Piekoszewski, W.7
Nowak, R.J.8
Opoka, W.9
Nowak, G.10
-
83
-
-
84918531983
-
Serum Trace Elements in Animal Models and Human Depression. Part I
-
Nowak, G.; Zięba, A.; Dudek, D.; Krośniak, M.; Szymaczek, M.; Schlegel-Zawadzka, M. Serum Trace Elements in Animal Models and Human Depression. Part I . Zinc, 1999, 86, 83-6.
-
(1999)
Zinc
, vol.86
, pp. 83-86
-
-
Nowak, G.1
Zięba, A.2
Dudek, D.3
Krośniak, M.4
Szymaczek, M.5
Schlegel-Zawadzka, M.6
-
84
-
-
1642503034
-
Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study
-
Nowak, G.; Siwek, M.; Dudek, D.; Zięba, A.; Pilc, A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Pol. J. Pharmacol., 2003, 55(6), 1143-7.
-
(2003)
Pol. J. Pharmacol
, vol.55
, Issue.6
, pp. 1143-1147
-
-
Nowak, G.1
Siwek, M.2
Dudek, D.3
Zięba, A.4
Pilc, A.5
-
85
-
-
84886727136
-
Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims
-
Sowa-Kućma, M.; Szewczyk, B.; Sadlik, K.; Piekoszewski, W.; Trela, F.; Opoka, W.; Poleszak, E.; Pilc, A.; Nowak, G. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J. Affect. Disord., 2013, 151(3), 924-31. doi:10. 1016/j.jad.2013.08.009.
-
(2013)
J. Affect. Disord
, vol.151
, Issue.3
, pp. 924-931
-
-
Sowa-Kućma, M.1
Szewczyk, B.2
Sadlik, K.3
Piekoszewski, W.4
Trela, F.5
Opoka, W.6
Poleszak, E.7
Pilc, A.8
Nowak, G.9
-
86
-
-
0042031163
-
Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims
-
Nowak, G.; Szewczyk, B.; Sadlik, K.; Piekoszewski, W.; Trela, F.; Florek, E.; Pilc, A. Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol. J. Pharmacol., 2003, 55(3), 455-9.
-
(2003)
Pol. J. Pharmacol
, vol.55
, Issue.3
, pp. 455-459
-
-
Nowak, G.1
Szewczyk, B.2
Sadlik, K.3
Piekoszewski, W.4
Trela, F.5
Florek, E.6
Pilc, A.7
-
87
-
-
33845883349
-
GPR39 signaling is stimulated by zinc ions but not by obestatin
-
Holst, B.; Egerod, K.L.; Schild, E.; Vickers, S.P.; Cheetham, S.; Gerlach, L.O.; Storjohann, L.; Stidsen, C.E.; Jones, R.; Beck-Sickinger, A.G.; Schwartz, T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology, 2007, 148(1), 13-20. doi:10.1210/en.2006-0933.
-
(2007)
Endocrinology
, vol.148
, Issue.1
, pp. 13-20
-
-
Holst, B.1
Egerod, K.L.2
Schild, E.3
Vickers, S.P.4
Cheetham, S.5
Gerlach, L.O.6
Storjohann, L.7
Stidsen, C.E.8
Jones, R.9
Beck-Sickinger, A.G.10
Schwartz, T.W.11
-
88
-
-
33744466554
-
GPR39 receptor expression in the mouse brain
-
Jackson, V.R.; Nothacker, H.-P.; Civelli, O. GPR39 receptor expression in the mouse brain. Neuroreport, 2006, 17(8), 813-6. doi:10.1097/01.wnr.0000215779.76602.93.
-
(2006)
Neuroreport
, vol.17
, Issue.8
, pp. 813-816
-
-
Jackson, V.R.1
Nothacker, H.-P.2
Civelli, O.3
-
89
-
-
63849207439
-
Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus
-
Besser, L.; Chorin, E.; Sekler, I.; Silverman, W.F.; Atkin, S.; Russell, J.T.; Hershfinkel, M. Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J. Neurosci., 2009, 29(9), 2890-901. doi:10.1523/ JNEUROSCI.5093-08.2009.
-
(2009)
J. Neurosci
, vol.29
, Issue.9
, pp. 2890-2901
-
-
Besser, L.1
Chorin, E.2
Sekler, I.3
Silverman, W.F.4
Atkin, S.5
Russell, J.T.6
Hershfinkel, M.7
-
90
-
-
84891588699
-
The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims
-
Młyniec, K.; Doboszewska, U.; Szewczyk, B.; Sowa-Kućma, M.; Misztak, P.; Piekoszewski, W.; Trela, F.; Ostachowicz, B.; Nowak, G. The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims. Neuropharmacology, 2014, 79, 290-7. doi:10. 1016/j.neuropharm.2013.12.001.
-
(2014)
Neuropharmacology
, vol.79
, pp. 290-297
-
-
Młyniec, K.1
Doboszewska, U.2
Szewczyk, B.3
Sowa-Kućma, M.4
Misztak, P.5
Piekoszewski, W.6
Trela, F.7
Ostachowicz, B.8
Nowak, G.9
-
91
-
-
84918579143
-
GPR39 Zn(2+)-sensing receptor: A new target in antidepressant development?
-
Młyniec, K.; Singewald, N.; Holst, B.; Nowak, G GPR39 Zn(2+)-sensing receptor: A new target in antidepressant development? J. Affect. Disord., 2015, 174C, 89-100. doi:10.1016/j.jad.2014.11.033.
-
(2015)
J. Affect. Disord
, vol.174 C
, pp. 89-100
-
-
Młyniec, K.1
Singewald, N.2
Holst, B.3
Nowak, G.4
-
92
-
-
0035949725
-
Ca2+ and regulates ion transport
-
Ca2+ and regulates ion transport. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(20), 11749-54. doi:10.1073/pnas.201193398.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A
, vol.98
, Issue.20
, pp. 11749-11754
-
-
Hershfinkel, M.1
Moran, A.2
Grossman, N.3
Sekler, I.4
-
93
-
-
11144225093
-
Common structural basis for constitutive activity of the ghrelin receptor family
-
Holst, B.; Holliday, N.D.; Bach, A.; Elling, C.E.; Cox, H.M.; Schwartz, T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem., 2004, 279(51), 53806-17. doi:10.1074/jbc.M407676200.
-
(2004)
J. Biol. Chem
, vol.279
, Issue.51
, pp. 53806-53817
-
-
Holst, B.1
Holliday, N.D.2
Bach, A.3
Elling, C.E.4
Cox, H.M.5
Schwartz, T.W.6
-
94
-
-
78650983010
-
GPR39: A Zn(2+)-activated G proteincoupled receptor that regulates pancreatic, gastrointestinal and neuronal functions
-
Popovics, P.; Stewart, A.J. GPR39: a Zn(2+)-activated G proteincoupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol. Life Sci., 2011, 68(1), 85-95. doi:10.1007/s00018-010-0517-1.
-
(2011)
Cell Mol. Life Sci
, vol.68
, Issue.1
, pp. 85-95
-
-
Popovics, P.1
Stewart, A.J.2
-
95
-
-
0029992189
-
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
-
Nibuya, M.; Nestler, E.J.; Duman, R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci., 1996, 16(7), 2365-72.
-
(1996)
J. Neurosci
, vol.16
, Issue.7
, pp. 2365-2372
-
-
Nibuya, M.1
Nestler, E.J.2
Duman, R.S.3
-
96
-
-
85005865085
-
GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus
-
Młyniec, K.; Budziszewska, B.; Holst, B.; Ostachowicz, B.; Nowak, G. GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus. Int. J. Neuropsychopharmacol., 2014, pyu002. doi:10.1093/ijnp/pyu002.
-
(2014)
Int. J. Neuropsychopharmacol
-
-
Młyniec, K.1
Budziszewska, B.2
Holst, B.3
Ostachowicz, B.4
Nowak, G.5
-
97
-
-
84875943880
-
GPR39 up-regulation after selective antidepressants
-
Młyniec, K.; Nowak, G. GPR39 up-regulation after selective antidepressants. Neurochem. Int., 2013, 62(7), 936-9. doi: 10.1016/ j.neuroint.2013.02.024
-
(2013)
Neurochem. Int
, vol.62
, Issue.7
, pp. 936-939
-
-
Młyniec, K.1
Nowak, G.2
-
98
-
-
80052567863
-
Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor
-
Chorin, E.; Vinograd, O.; Fleidervish, I.; Gilad, D.; Herrmann, S.; Sekler, I.; Aizenman, E.; Hershfinkel, M. Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor. J. Neurosci., 2011, 31(36), 12916-26. doi:10.1523/ JNEUROSCI.2205-11.2011.
-
(2011)
J. Neurosci
, vol.31
, Issue.36
, pp. 12916-12926
-
-
Chorin, E.1
Vinograd, O.2
Fleidervish, I.3
Gilad, D.4
Herrmann, S.5
Sekler, I.6
Aizenman, E.7
Hershfinkel, M.8
-
99
-
-
84939889393
-
K-Cl cotransporter KCC2-a moonlighting protein in excitatory and inhibitory synapse development and function
-
Blaesse, P.; Schmidt, T. K-Cl cotransporter KCC2-a moonlighting protein in excitatory and inhibitory synapse development and function. Pflugers Arch., 2014, 467. doi:10.1007/s00424-014-1547-6.
-
(2014)
Pflugers Arch
, pp. 467
-
-
Blaesse, P.1
Schmidt, T.2
-
100
-
-
77949912354
-
Enhanced expression of the neuronal K+/Cl-cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats
-
Matrisciano, F.; Nasca, C.; Molinaro, G.; Riozzi, B.; Scaccianoce, S.; Raggi, M.A.; Mercolini, L.; Biagioni, F.; Mathe, A.A.; Sanna, E.; Maciocco, E.; Pignatelli, M.; Biggio, G.; Nicoletti, F. Enhanced expression of the neuronal K+/Cl-cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats. Brain Res., 2010, 1325, 112-20. doi:10.1016/j.brainres.2010.02.017.
-
(2010)
Brain Res
, vol.1325
, pp. 112-120
-
-
Matrisciano, F.1
Nasca, C.2
Molinaro, G.3
Riozzi, B.4
Scaccianoce, S.5
Raggi, M.A.6
Mercolini, L.7
Biagioni, F.8
Mathe, A.A.9
Sanna, E.10
Maciocco, E.11
Pignatelli, M.12
Biggio, G.13
Nicoletti, F.14
-
101
-
-
84878278646
-
Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis
-
Perez-Rosello, T.; Anderson, C.T.; Schopfer, F.J.; Zhao, Y.; Gilad, D.; Salvatore, S.R.; Freeman, B.A.; Hershfinkel, M.; Aizenman, E.; Tzounopopulos, T. Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis. J. Neurosci., 2013, 33(22), 9259-72. doi: 10.1523/JNEUROSCI.0237-13.2013.
-
(2013)
J. Neurosci
, vol.33
, Issue.22
, pp. 9259-9272
-
-
Perez-Rosello, T.1
Anderson, C.T.2
Schopfer, F.J.3
Zhao, Y.4
Gilad, D.5
Salvatore, S.R.6
Freeman, B.A.7
Hershfinkel, M.8
Aizenman, E.9
Tzounopopulos, T.10
-
102
-
-
34047219231
-
Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF
-
Li, B., Suemaru, K., Kitamura, Y., Cui, R., Gomita, Y., Araki, H. Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF. Yakugaku Zasshi, 2007, 127(4), 735-42.
-
(2007)
Yakugaku Zasshi
, vol.127
, Issue.4
, pp. 735-742
-
-
Li, B.1
Suemaru, K.2
Kitamura, Y.3
Cui, R.4
Gomita, Y.5
Araki, H.6
-
103
-
-
84886822307
-
Additive antidepressant-like effects of fasting with imipramine via modulation of 5-HT2 receptors in the mice
-
Li, B., Zhao, J., Lv, J., Tang, F., Liu, L., Sun, Z., Wang, L., Siwela, S.P., Wang, Y., Song, Y., Manchishi, S.M., Cui, R. Additive antidepressant-like effects of fasting with imipramine via modulation of 5-HT2 receptors in the mice. Prog. Neuropsychopharmacol Biol Psychiatry, 2014, 48, 199-206. doi: 10.1016/j.pnpbp.2013.08.015.
-
(2014)
Prog. Neuropsychopharmacol Biol Psychiatry
, vol.48
, pp. 199-206
-
-
Li, B.1
Zhao, J.2
Lv, J.3
Tang, F.4
Liu, L.5
Sun, Z.6
Wang, L.7
Siwela, S.P.8
Wang, Y.9
Song, Y.10
Manchishi, S.M.11
Cui, R.12
-
104
-
-
66149110404
-
Triple reuptake inhibitors: The next generation of antidepressants
-
Marks, D.M., Pae, C.U., Patkar, A.A. Triple reuptake inhibitors: the next generation of antidepressants. Curr. Neuropharmacol. 2008, 6(4), 338-43. doi: 10.2174/157015908787386078.
-
(2008)
Curr. Neuropharmacol
, vol.6
, Issue.4
, pp. 338-343
-
-
Marks, D.M.1
Pae, C.U.2
Patkar, A.A.3
|